Skip to main content

Advertisement

SpringerLink
Log in

Factors influencing the willingness of US women to vaccinate their daughters against the human papillomavirus to prevent cervical cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The human papillomavirus (HPV) vaccine helps to prevent cervical cancer. However, research indicates that public acceptance of the vaccine is suboptimal. Our aims were to evaluate the willingness of US women to use the HPV vaccine in their daughters, examine their current understanding of HPV, and determine the impact of HPV knowledge and other socio-demographic factors on their willingness to get their daughters vaccinated. Women aged ≥18 years were identified from the US Health Information National Trends Survey. We developed a 6-point composite scoring system based on individual responses to HPV-related questions to characterize personal understanding about HPV. Logistic regression models were constructed to explore the influence of the women’s HPV knowledge level and additional socio-demographic factors on the willingness to use HPV in their daughters. There were 804 female respondents: mean age was 44.9 (SD = 2.53) years and 73 % were White. In total, 75 % of women indicated they would vaccinate their daughters against HPV. Mean knowledge score was 4.6 (SD = 0.80). While White race was associated with higher willingness to use the vaccine in their daughters (OR = 1.86, p = 0.04), HPV knowledge level was not (OR = 0.47, p = 0.22). Among US women, HPV knowledge level was high, but it was not associated with the willingness to vaccinate their daughters against HPV. Interventions focused on alleviating racial disparities might better modify the use of the HPV vaccine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  PubMed  CAS  Google Scholar 

  2. SEER Cancer Statistics Review (1975–2007) National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010: 2010. http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.

  3. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA. 1983;80:3812–5.

    Article  PubMed  CAS  Google Scholar 

  4. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984;3:1151–7.

    PubMed  CAS  Google Scholar 

  5. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796–802.

    Article  PubMed  CAS  Google Scholar 

  6. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.

    Article  PubMed  CAS  Google Scholar 

  7. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27.

    Article  PubMed  Google Scholar 

  8. Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303–15.

    Article  PubMed  Google Scholar 

  9. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6:204.

    Article  PubMed  Google Scholar 

  10. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072–9.

    Article  PubMed  Google Scholar 

  11. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621–32.

    Article  PubMed  CAS  Google Scholar 

  12. Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology. 1991;185:251–7.

    Article  PubMed  CAS  Google Scholar 

  13. Ghim SJ, Jenson AB, Schlegel R. HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology. 1992;190:548–52.

    Article  PubMed  CAS  Google Scholar 

  14. Rose RC, Bonnez W, Reichman RC, Garcea RL. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol. 1993;67:1936–44.

    PubMed  CAS  Google Scholar 

  15. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928–43.

    Article  PubMed  CAS  Google Scholar 

  16. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915–27.

    Article  Google Scholar 

  17. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369:2161–70.

    Article  PubMed  CAS  Google Scholar 

  18. Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298:743–53.

    Article  PubMed  CAS  Google Scholar 

  19. Mosher WD, Chandra A, Jones J. Sexual behavior and selected health measures: men and women 15–44 years of age, United States. Adv Data. 2002;2005:1–55.

    Google Scholar 

  20. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40:108–15.

    Article  PubMed  Google Scholar 

  21. Bernat DH, Harpin SB, Eisenberg ME, Bearinger LH, Resnick MD. Parental support for the human papillomavirus vaccine. J Adolesc Health. 2009;45:525–7.

    Article  PubMed  Google Scholar 

  22. Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19:531–8.

    Article  PubMed  Google Scholar 

  23. Jain N, Stokley S, Yankey MA. Centers for disease control and prevention. Vaccination coverage among adolescents aged 13–17 years-United States, 2007. MMWR2008:1100–1103.

  24. Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2009.

  25. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009;45:453–62.

    Article  PubMed  Google Scholar 

  26. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010;171:357–67.

    Article  PubMed  Google Scholar 

  27. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45:528–31.

    Article  PubMed  Google Scholar 

  28. Cantor DCK, Crystal-Mansour S, Davis T, Dipko S, Sigman R.: Health Information National Trends Survey (HINTS) 2007 Final Report. In: Rockville M, editor. Westat2009.

  29. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45:107–14.

    Article  PubMed  Google Scholar 

  30. Holcomb B, Bailey JM, Crawford K, Ruffin MTt. Adults’ knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract. 2004;17:26–31.

    Article  PubMed  Google Scholar 

  31. Behbakht K, Lynch A, Teal S, Degeest K, Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol. 2004;104:1355–61.

    Article  PubMed  Google Scholar 

  32. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the US know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007;16:288–94.

    Article  PubMed  Google Scholar 

  33. Brownson RC, Jackson-Thompson J, Wilkerson JC, Davis JR, Owens NW, Fisher EB Jr. Demographic and socioeconomic differences in beliefs about the health effects of smoking. Am J Public Health. 1992;82:99–103.

    Article  PubMed  CAS  Google Scholar 

  34. Manderbacka K, Lundberg O, Martikainen P. Do risk factors and health behaviours contribute to self-ratings of health? Soc Sci Med. 1999;48:1713–20.

    Article  PubMed  CAS  Google Scholar 

  35. Wynd CA. Smoking patterns, beliefs, and the practice of healthy behaviors in abstinent, relapsed, and recalcitrant smokers. J Vasc Nurs. 2007;25:32–8.

    Article  PubMed  Google Scholar 

  36. Boehner CW, Howe SR, Bernstein DI, Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis. 2003;30:774–8.

    Article  PubMed  Google Scholar 

  37. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8:188–94.

    Article  PubMed  Google Scholar 

  38. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS. 2003;14:300–6.

    Article  PubMed  Google Scholar 

  39. Lemon SC, Rakowski W, Clark MA, Roy J, Friedmann PD. Variations in influenza vaccination among the elderly. Am J Health Behav. 2004;28:352–60.

    Article  PubMed  Google Scholar 

  40. Hoover DR, Sambamoorthi U, Crystal S. Characteristics of community dwelling elderly not vaccinated for pneumococcus in 1998 and 2001. Prev Med. 2004;39:517–27.

    Article  PubMed  Google Scholar 

  41. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged >or =65 years–United States, 2001. JAMA. 2002;288:2815–7.

    Article  Google Scholar 

  42. Chen JY, Fox SA, Cantrell CH, Stockdale SE, Kagawa-Singer M. Health disparities and prevention: racial/ethnic barriers to flu vaccinations. J Community Health. 2007;32:5–20.

    Article  PubMed  Google Scholar 

  43. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117:1486–93.

    Article  PubMed  Google Scholar 

  44. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health. 2005;37:248–51.

    Article  PubMed  Google Scholar 

  45. Gamble HL, Klosky JL, Parra GR, Randolph ME: Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol. 2009.

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Medical Oncology, British Columbia Cancer Agency, Vancouver Clinic, 600 W. 10th Ave, Vancouver, BC, V5Z 4E6, Canada

    Jennifer Y. Lai, Anna V. Tinker & Winson Y. Cheung

Authors
  1. Jennifer Y. Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna V. Tinker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Winson Y. Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Winson Y. Cheung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lai, J.Y., Tinker, A.V. & Cheung, W.Y. Factors influencing the willingness of US women to vaccinate their daughters against the human papillomavirus to prevent cervical cancer. Med Oncol 30, 582 (2013). https://doi.org/10.1007/s12032-013-0582-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0582-z

Keywords

Search

Navigation